Capital Planning Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-927
| Closed | -$251K | – | 138 |
|
|
2024
Q1 | $251K | Sell |
927
-12
| -1% | -$3.25K | 0.04% | 128 |
|
|
2023
Q4 | $222K | Buy |
+939
| New | +$222K | 0.04% | 125 |
|
|
2022
Q3 | – | Sell |
-950
| Closed | -$203K | – | 124 |
|
|
2022
Q2 | $203K | Sell |
950
-31
| -3% | -$6.62K | 0.05% | 127 |
|
|
2022
Q1 | $279K | Buy |
981
+31
| +3% | +$8.82K | 0.06% | 133 |
|
|
2021
Q4 | $358K | Hold |
950
| – | – | 0.07% | 119 |
|
|
2021
Q3 | $392K | Hold |
950
| – | – | 0.08% | 115 |
|
|
2021
Q2 | $351K | Hold |
950
| – | – | 0.07% | 116 |
|
|
2021
Q1 | $275K | Buy |
950
+40
| +4% | +$11.6K | 0.06% | 116 |
|
|
2020
Q4 | $227K | Hold |
910
| – | – | 0.06% | 119 |
|
|
2020
Q3 | $206K | Buy |
+910
| New | +$206K | 0.06% | 119 |
|